• 1. Jining Medical University, Jining 272000, China;
  • 2. Department of Neurology, Affiliated Hospital of Jining Medical University, Jining 272000, China;
ZHANG Yanke, Email: yankezhang@mail.jnmc.edu.cn
Export PDF Favorites Scan Get Citation

Surgical removal or destruction of the focal brain area is the main treatment for drug-resistant epilepsy, but it is not suitable for all patients. Epileptiologists in the United States have opted for a new type of palliative therapy called responsive neurostimulation (RNS). The RNS system continuously monitors the electrical activity of the brain in the area of possible seizures and places electrodes in the epileptic area to provide electrical stimulation when abnormal discharges are detected, stopping seizures. Controlled clinical trials have demonstrated the long-term effectiveness and safety of the RNS system, with continued improvement in seizure reduction rates over time. RNS system not only has a good effect on temporal lobe epilepsy and cortical functional area epilepsy, but also can dynamically monitor cortical EEG, so as to better understand the epilepsy status of each patient and provide personalized diagnosis and treatment. In this paper, the development history, structure, advantages and disadvantages of RNS system are reviewed, and its indications as palliative treatment for drug-resistant epilepsy are discussed.

Citation: GUO Yafeng, LI Xi, ZHANG Yanke. Responsive neurostimulation: a new treatment option for refractory epilepsy. Journal of Epilepsy, 2023, 9(6): 509-512. doi: 10.7507/2096-0247.202307012 Copy

  • Previous Article

    Research progress on correlation between febrile seizure and trace elements in children
  • Next Article

    Clinical characteristics of autoimmune encephalitis in common antibody types and epileptic seizures